UCL Cancer Institute


Online: Clinical Seminar Series - Jonathan Ledermann and Khurum Khan

18 June 2020, 10:00 am–11:00 am


In this seminar Prof Jonathan Ledermann discusses PARP inhibitors as targeted practice-changing therapy for ovarian cancers and Dr Khuram Khan explains more about liquid biopsies in colorectal cancer and personalised medicine.

Event Information

Open to



Veronica Dominguez


Prof Jonathan Ledermann
Seminar title: PARP inhibitors in ovarian cancer - how far have we come, where should we go? 

Professor Ledermann is a Consultant Medical Oncologist at UCLH, Clinical Director of the UCL Cancer Institute and Director of the Cancer Research UK and UCL Cancer Trials Centre. His principal area of clinical practice and research is in gynaecological cancers. He has led many national and international clinical trials in ovarian cancer. 

Dr Khurum Khan
Seminar title: Liquid biopsies in colorectal cancer- are we a step closer to personalised medicine?

Dr Khan is an Honorary Associate Professor and Consultant in Gastrointestinal Oncology at UCLH. His main research interests involve stratification of therapies in patients with gastrointestinal malignancies, by setting up studies of clinical and translational relevance.

Seminar recording

You will need your UCL username and password to view this recording

View recording on UCL Mediacentral